Chiasma Inc. (CHMA) NASDAQ

$3.76 0 (0.00%)

Market Cap: $0

As of 08/05/21 12:00 AM EDT. Market closed.

(CHMA)

Chiasma Inc. (CHMA) NASDAQ

$3.76 0 (0.00%)

Market Cap: $0

As of 08/05/21 12:00 AM EDT. Market closed.

Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only ... read more

Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. In June 2020, Chiasma received FDA approval of MYCAPSSA for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA, the first and only oral somatostatin analog approved by the FDA, is available for commercial sale. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Raj Kannan
Full Time Employees
85
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.04M
URL
Address
140 Kendrick Street, Building C East, Massachusetts, Needham, 02494.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Raj Kannan
Full Time Employees
85
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.04M
Address
140 Kendrick Street, Building C East, Massachusetts, Needham, 02494.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$3.76
Previous Close
$3.76
Days Range
$3.76 - $4.10
52 week range
$0 - $0
Volume
8,196,718
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
57,894,177
Open
$3.76
Previous Close
$3.76
Days Range
$3.76 - $4.10
52 week range
$0 - $0
Volume
8,196,718
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
57,894,177

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CHIASMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Mamluk RoniDirectorFeb 09, 2021 Option Exercise$1.8527,98151,76527,981Feb 11, 2021, 05:39 PM
Mamluk RoniDirectorFeb 09, 2021 Sale$5.0027,981139,9050Feb 11, 2021, 05:39 PM
Fitzpatrick Mark J.PresidentDec 04, 2020 Option Exercise$2.6010,00026,00019,612Dec 07, 2020, 04:35 PM
STACK DAVID MDirectorNov 30, 2020 Buy$4.2725,000106,85825,000Dec 01, 2020, 07:40 PM
KANNAN RAJChief Executive OfficerNov 23, 2020 Buy$4.00120,000480,492137,095Nov 24, 2020, 06:01 PM
KANNAN RAJChief Executive OfficerJul 14, 2020 Buy$4.2010,00042,00017,095Jul 15, 2020, 06:57 PM
Mamluk RoniDirectorFeb 20, 2020 Option Exercise$0.0982,1867,39782,186Feb 21, 2020, 04:43 PM
Mamluk RoniDirectorFeb 20, 2020 Sale$4.5482,186373,1240Feb 21, 2020, 04:43 PM
Mamluk RoniDirectorDec 20, 2019 Option Exercise$0.0961,1395,50361,139Dec 23, 2019, 04:10 PM
Mamluk RoniDirectorDec 20, 2019 Sale$5.5161,139336,8760Dec 23, 2019, 04:10 PM
Mamluk RoniDirectorOct 16, 2019 Option Exercise$0.0910,00090010,000Oct 17, 2019, 08:23 PM
Mamluk RoniDirectorOct 16, 2019 Sale$4.9410,00049,4000Oct 17, 2019, 08:23 PM
LUDLAM WILLIAMSee RemarksSep 27, 2019 Buy$4.915,05024,78311,799Sep 27, 2019, 05:34 PM
Mamluk RoniDirectorSep 20, 2019 Option Exercise$0.0950,0004,50050,000Sep 23, 2019, 04:08 PM
Mamluk RoniDirectorSep 20, 2019 Sale$5.5950,000279,5000Sep 23, 2019, 04:08 PM
Minick ScottDirectorAug 19, 2019 Buy$5.024,30021,58681,676Aug 21, 2019, 04:16 PM
Minick ScottDirectorAug 20, 2019 Buy$5.335,51829,41187,194Aug 21, 2019, 04:16 PM
Mamluk RoniDirectorJul 16, 2019 Option Exercise$0.0910,00090010,000Jul 17, 2019, 07:40 PM
Mamluk RoniDirectorJul 16, 2019 Sale$6.3510,00063,5000Jul 17, 2019, 07:40 PM
Mamluk RoniDirectorApr 16, 2019 Option Exercise$0.0910,00090010,000Apr 17, 2019, 05:19 PM
Mamluk RoniDirectorApr 16, 2019 Sale$5.3110,00053,1000Apr 17, 2019, 05:19 PM
LUDLAM WILLIAMSee RemarksApr 01, 2019 Buy$5.001,6258,1256,749Apr 02, 2019, 06:49 PM
Mamluk RoniDirectorMar 05, 2019 Option Exercise$0.095,0004505,000Mar 06, 2019, 04:34 PM
Mamluk RoniDirectorMar 05, 2019 Sale$5.005,00025,0000Mar 06, 2019, 04:34 PM
Mamluk RoniDirectorJan 22, 2019 Option Exercise$0.095,0004505,000Jan 23, 2019, 05:43 PM
Mamluk RoniDirectorJan 22, 2019 Sale$3.675,00018,3700Jan 23, 2019, 05:43 PM
Fitzpatrick Mark J.President and CEODec 20, 2018 Buy$2.509,61224,0309,612Dec 21, 2018, 02:03 PM
Minick ScottDirectorSep 18, 2018 Buy$3.074,00012,28063,220Sep 20, 2018, 09:21 PM
Minick ScottDirectorSep 20, 2018 Buy$3.0913,00040,17084,220Sep 20, 2018, 09:21 PM
Minick ScottDirectorSep 19, 2018 Buy$3.068,00024,48071,220Sep 20, 2018, 09:21 PM
Mamluk RoniDirectorJun 18, 2018 Option Exercise$0.092,3892152,389Jun 20, 2018, 05:19 PM
Mamluk RoniDirectorJun 18, 2018 Sale$1.462,3893,4840Jun 20, 2018, 05:19 PM
Mamluk RoniDirectorMar 19, 2018 Option Exercise$0.092,3892152,389Mar 20, 2018, 04:32 PM
Mamluk RoniDirectorMar 19, 2018 Sale$1.532,3893,6550Mar 20, 2018, 04:32 PM
Mamluk RoniDirectorDec 18, 2017 Option Exercise$0.092,3892152,389Dec 19, 2017, 04:33 PM
Mamluk RoniDirectorDec 18, 2017 Sale$1.752,3894,1810Dec 19, 2017, 04:33 PM
Mamluk RoniDirectorOct 24, 2017 Option Exercise$0.092,3892152,389Oct 26, 2017, 04:06 PM
Mamluk RoniDirectorOct 24, 2017 Sale$2.272,3895,4300Oct 26, 2017, 04:06 PM
Minick ScottDirectorSep 21, 2017 Buy$2.3610,00023,56959,220Sep 22, 2017, 04:42 PM
Minick ScottDirectorSep 20, 2017 Buy$2.3815,00035,69049,220Sep 22, 2017, 04:42 PM
7-MED Health Ventures LP10% OwnerJul 21, 2015 Buy$16.0093,7501,500,00093,750Jul 23, 2015, 05:45 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Mamluk RoniDirector02/09/202151,765
Mamluk RoniDirector02/09/2021139,905
Fitzpatrick Mark J.President12/04/202026,000
STACK DAVID MDirector11/30/2020106,858
KANNAN RAJChief Executive Officer11/23/2020480,492
KANNAN RAJChief Executive Officer07/14/202042,000
Mamluk RoniDirector02/20/20207,397
Mamluk RoniDirector02/20/2020373,124
Mamluk RoniDirector12/20/20195,503
Mamluk RoniDirector12/20/2019336,876
Mamluk RoniDirector10/16/2019900
Mamluk RoniDirector10/16/201949,400
LUDLAM WILLIAMSee Remarks09/27/201924,783
Mamluk RoniDirector09/20/20194,500
Mamluk RoniDirector09/20/2019279,500
Minick ScottDirector08/19/201921,586
Minick ScottDirector08/20/201929,411
Mamluk RoniDirector07/16/2019900
Mamluk RoniDirector07/16/201963,500
Mamluk RoniDirector04/16/2019900
Mamluk RoniDirector04/16/201953,100
LUDLAM WILLIAMSee Remarks04/01/20198,125
Mamluk RoniDirector03/05/2019450
Mamluk RoniDirector03/05/201925,000
Mamluk RoniDirector01/22/2019450
Mamluk RoniDirector01/22/201918,370
Fitzpatrick Mark J.President and CEO12/20/201824,030
Minick ScottDirector09/18/201812,280
Minick ScottDirector09/20/201840,170
Minick ScottDirector09/19/201824,480
Mamluk RoniDirector06/18/2018215
Mamluk RoniDirector06/18/20183,484
Mamluk RoniDirector03/19/2018215
Mamluk RoniDirector03/19/20183,655
Mamluk RoniDirector12/18/2017215
Mamluk RoniDirector12/18/20174,181
Mamluk RoniDirector10/24/2017215
Mamluk RoniDirector10/24/20175,430
Minick ScottDirector09/21/201723,569
Minick ScottDirector09/20/201735,690
7-MED Health Ventures LP10% Owner07/21/20151,500,000
Load More Insider Transactions